Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE

Rank in Stocks #663
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Share Price
$19.29
Last synced: 2026-10-20
Market Cap
$37.05B
Change (1 day)
2.23%
Change (1 year)
29.20%
Country
US
Trade Kenvue Inc. (KVUE)

Category

Consumer Defensive
P/E ratio for Kenvue Inc. (KVUE)
P/E ratio as of October 2026 TTM: 20.70
According to Kenvue Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 20.70. At the end of 2023 the company had a P/E ratio of 23.92.
P/E ratio history for Kenvue Inc. from 2019 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 20.70 -47.43%
2024 39.38 64.61%
2023 23.92 -4.15%
2022 24.96 2.06%
2021 24.45 -142.30%
2020 -57.81 -263.25%
2019 35.41 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
23.20 12.05%
US
32.48 56.91%
FR
36.47 76.17%
US
29.80 43.97%
IN
199.20 862.25%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.